Works matching DE "RIFAMPIN"
Results: 3705
Solution reduces infection risk in penile prosthesis.
- Published in:
- Urology Times, 2011, v. 39, n. 3, p. 20
- By:
- Publication type:
- Article
Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Add or switch to systemics and biologics where topical paediatric hidradenitis suppurativa therapy fails.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 6, p. 211, doi. 10.1007/s40267-024-01076-7
- By:
- Publication type:
- Article
Ocular surface leproma.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Current status of multidrug resistant tuberculosis in a tertiary care hospital of East Delhi.
- Published in:
- Journal of Postgraduate Medicine, 2013, v. 59, n. 3, p. 173, doi. 10.4103/0022-3859.118031
- By:
- Publication type:
- Article
Resistance pattern in drug-resistant pulmonary tuberculosis.
- Published in:
- Journal of Postgraduate Medicine, 2011, v. 57, n. 3, p. 181, doi. 10.4103/0022-3859.85197
- By:
- Publication type:
- Article
Treatment of leprosy in India.
- Published in:
- Journal of Postgraduate Medicine, 2009, v. 55, n. 3, p. 220, doi. 10.4103/0022-3859.57410
- By:
- Publication type:
- Article
Intrahepatic cholestasis of pregnancy – Diagnosis and management: A consensus statement of the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ): Executive summary.
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 2023, v. 63, n. 5, p. 656, doi. 10.1111/ajo.13719
- By:
- Publication type:
- Article
Bacterial Outer Membrane‐Coated Mesoporous Silica Nanoparticles for Targeted Delivery of Antibiotic Rifampicin against Gram‐Negative Bacterial Infection In Vivo.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 35, p. 1, doi. 10.1002/adfm.202103442
- By:
- Publication type:
- Article
Tuning the porosity of hypercrosslinked styrene-divinylbenzene copolymers for efficient adsorption of rifampicin from aqueous media.
- Published in:
- Journal of Polymer Research, 2023, v. 30, n. 11, p. 1, doi. 10.1007/s10965-023-03802-7
- By:
- Publication type:
- Article
Potential interactions between irinotecan and rifampin in a patient with small-cell lung cancer.
- Published in:
- International Journal of Clinical Oncology, 2004, v. 9, n. 3, p. 206, doi. 10.1007/s10147-004-0394-4
- By:
- Publication type:
- Article
Management of rifamycins-everolimus drug-drug interactions in a liver-transplant patient with pulmonary tuberculosis.
- Published in:
- Transplant International, 2012, v. 25, n. 11, p. e120, doi. 10.1111/j.1432-2277.2012.01561.x
- By:
- Publication type:
- Article
The tale of microencapsulated rifampicin: is it useful for the treatment of periprosthetic joint infection?
- Published in:
- 2022
- By:
- Publication type:
- journal article
Factors affecting outcome in the treatment of streptococcal periprosthetic joint infections: results from a single-centre retrospective cohort study.
- Published in:
- International Orthopaedics, 2021, v. 45, n. 1, p. 57, doi. 10.1007/s00264-020-04722-7
- By:
- Publication type:
- Article
Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention.
- Published in:
- International Orthopaedics, 2015, v. 39, n. 9, p. 1785, doi. 10.1007/s00264-015-2819-2
- By:
- Publication type:
- Article
Pharmacokinetics-pharmacodynamics of first-line antitubercular drugs: a comparative study in tuberculosis patients with and without concomitant diabetes mellitus.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 12, p. 1945, doi. 10.1007/s00228-024-03754-x
- By:
- Publication type:
- Article
Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1271, doi. 10.1007/s00228-024-03697-3
- By:
- Publication type:
- Article
The effects of drug-drug interaction on linezolid pharmacokinetics: A systematic review.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 6, p. 785, doi. 10.1007/s00228-024-03652-2
- By:
- Publication type:
- Article
Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 6, p. 975, doi. 10.1007/s00228-022-03304-3
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 65, doi. 10.1007/s00228-021-03194-x
- By:
- Publication type:
- Article
A case series of the rifampin-warfarin drug interaction: focus on practical warfarin management.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 341, doi. 10.1007/s00228-020-03057-x
- By:
- Publication type:
- Article
Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 2, p. 223, doi. 10.1007/s00228-020-03004-w
- By:
- Publication type:
- Article
Identification of the caffeine to trimethyluric acid ratio as a dietary biomarker to characterise variability in cytochrome P450 3A activity.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 9, p. 1211, doi. 10.1007/s00228-019-02682-5
- By:
- Publication type:
- Article
Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 12, p. 1593, doi. 10.1007/s00228-018-2533-2
- By:
- Publication type:
- Article
Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 11, p. 1405, doi. 10.1007/s00228-018-2499-0
- By:
- Publication type:
- Article
Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 7, p. 913, doi. 10.1007/s00228-018-2450-4
- By:
- Publication type:
- Article
Effects of cytochrome P450 (CYP3A4 and CYP2C19) inhibition and induction on the exposure of selumetinib, a MEK1/2 inhibitor, in healthy subjects: results from two clinical trials.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 2, p. 175, doi. 10.1007/s00228-016-2153-7
- By:
- Publication type:
- Article
Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Effective CSF concentrations achieved with continuous-infusion flucloxacillin in a child.
- Published in:
- 2015
- By:
- Publication type:
- Letter
The effects of ketoconazole and rifampin on the single-dose pharmacokinetics of crizotinib in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 12, p. 1441, doi. 10.1007/s00228-015-1945-5
- By:
- Publication type:
- Article
Prolonged inductive effect of rifampicin on linezolid exposure.
- Published in:
- 2015
- By:
- Publication type:
- Letter
A pharmacometric pulmonary model predicting the extent and rate of distribution from plasma to epithelial lining fluid and alveolar cells-using rifampicin as an example.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 3, p. 313, doi. 10.1007/s00228-014-1798-3
- By:
- Publication type:
- Article
Comparison of two endogenous biomarkers of CYP3A4 activity in a drug-drug interaction study between midostaurin and rifampicin.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 8, p. 915, doi. 10.1007/s00228-014-1675-0
- By:
- Publication type:
- Article
Effect of a single-dose rifampin on the pharmacokinetics of pitavastatin in healthy volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 11, p. 1933, doi. 10.1007/s00228-013-1554-0
- By:
- Publication type:
- Article
Rifampicin markedly decreases the exposure to oral and intravenous tramadol.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 6, p. 1293, doi. 10.1007/s00228-012-1460-x
- By:
- Publication type:
- Article
Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 4, p. 877, doi. 10.1007/s00228-012-1436-x
- By:
- Publication type:
- Article
The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 689, doi. 10.1007/s00228-011-1166-5
- By:
- Publication type:
- Article
Interaction of flucloxacillin and quinidine.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 10, p. 1017, doi. 10.1007/s00228-010-0847-9
- By:
- Publication type:
- Article
Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 497, doi. 10.1007/s00228-010-0796-3
- By:
- Publication type:
- Article
Evaluation of drug–drug interactions with fesoterodine.
- Published in:
- European Journal of Clinical Pharmacology, 2009, v. 65, n. 6, p. 551, doi. 10.1007/s00228-009-0648-1
- By:
- Publication type:
- Article
Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV- and tuberculosis-infected South African patients.
- Published in:
- European Journal of Clinical Pharmacology, 2009, v. 65, n. 1, p. 71, doi. 10.1007/s00228-008-0481-y
- By:
- Publication type:
- Article
Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 6, p. 451, doi. 10.1007/s00228-006-0127-x
- By:
- Publication type:
- Article
Cytochrome P<sub>450</sub> mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 8, p. 583, doi. 10.1007/s00228-005-0971-0
- By:
- Publication type:
- Article
Oral administration of a low dose of midazolam (75 μg) as an in vivo probe for CYP3A activity.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 4, p. 237, doi. 10.1007/s00228-004-0762-z
- By:
- Publication type:
- Article
Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 2, p. 109, doi. 10.1007/s00228-004-0746-z
- By:
- Publication type:
- Article
Rifampicin reduces plasma concentrations of celiprolol.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 59, n. 11, p. 819, doi. 10.1007/s00228-003-0694-z
- By:
- Publication type:
- Article
The Microbiological and Clinical Effects of Combined Therapy according to Guidelines on the Treatment of Pulmonary Mycobacterium avium Complex Disease in Japan – Including a Follow-Up Study.
- Published in:
- Respiration, 2007, v. 74, n. 4, p. 394, doi. 10.1159/000095674
- By:
- Publication type:
- Article
Acute Respiratory Distress Syndrome Induced by Rifampicin with High Levels of Neutrophil and Eosinophil Products in Bronchoalveolar Lavage Fluid.
- Published in:
- Respiration, 2003, v. 70, n. 5, p. 541, doi. 10.1159/000074216
- By:
- Publication type:
- Article
Interception of host angiogenic signalling limits mycobacterial growth.
- Published in:
- Nature, 2015, v. 517, n. 7536, p. 612, doi. 10.1038/nature13967
- By:
- Publication type:
- Article